Overcoming the challenges of drug discovery for neglected tropical diseases: The A·WOL experience

Journal of Biomolecular Screening

Volumn 19, Issue 3, 2014, Pages 335-343

  Johnston, Kelly L ^a   Ford, Louise ^a   Taylor, Mark J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

lymphatic filariasis; neglected tropical diseases; onchocerciasis; review; Wolbachia

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; DOXYCYCLINE; FENARIMOL; MACROLIDE; MEBENDAZOLE; MINOCYCLINE; NEW DRUG; PHOSPHOTRANSFERASE INHIBITOR; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ARTICLE; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; HUMAN; LYMPHATIC FILARIASIS; NEGLECTED DISEASE; NONHUMAN; ONCHOCERCIASIS; PRIORITY JOURNAL; PUBLIC FIGURE; TROPICAL DISEASE; VISCERAL LEISHMANIASIS; WOLBACHIA; WORLD HEALTH ORGANIZATION;

LYMPHATIC FILARIASIS; NEGLECTED TROPICAL DISEASES; ONCHOCERCIASIS; REVIEW; WOLBACHIA;

DRUG DISCOVERY; ELEPHANTIASIS, FILARIAL; HUMANS; NEGLECTED DISEASES; ONCHOCERCIASIS; TROPICAL MEDICINE; WOLBACHIA; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84893830637     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057113511270     Document Type: Article

References (46)

1. Hotez P. J., Fenwick A., Savioli L., et al. Rescuing the Bottom Billion through Control of Neglected Tropical Diseases. Lancet. 2009 ; 373: 1570-1575
2. World Health Organization. Global Plan to Combat Neglected Tropical Diseases 2008-2015. 2007. http://whqlibdoc.who.int/hq/2007/WHO-CDS-NTD-2007. 2003-eng.pdf.
3. Hotez P. J., Pecoul B. "Manifesto" for Advancing the Control and Elimination of Neglected Tropical Diseases. PLoS Negl. Trop. Dis. 2010 ; 4: e718
4. World Health Organization. Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation. 2012. http://whqlibdoc.who.int/hq/2012/WHO-HTM-NTD-2012.2011-eng.pdf.
5. World Health Organization. London Declaration on Neglected Tropical Diseases. 2012. http://www.who.int/neglected-diseases/London-Declaration-NTDs. pdf.
6. Molyneux D. H. The 'Neglected Tropical Diseases': Now a Brand Identity; Responsibilities, Context and Promise. Parasit. Vectors. 2012 ; 5: 23
7. Uniting to Combat NTDs. From Promises to Progress: The First Annual Report on the London Declaration on NTDs. 2013. http://www.unitingtocombatntds. org/reports/promises-to-progress-EN.pdf.
8. World Health Organization. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases: Second WHO Report on Neglected Tropical Diseases. 2013. http://www.who.int/iris/bitstream/10665/77950/10661/ 9789241564540-eng.pdf.
9. Uniting to Combat NTDs. Uniting to Combat Neglected Tropical Diseases: Translating the London Declaration into Action. 2012. http://www. unitingtocombatntds.org/reports/UTCNTDs-Meeting-Report.pdf.
10. Hotez P. J. Engaging a Rising China through Neglected Tropical Diseases. PLoS Negl. Trop. Dis. 2012 ; 6: e1599
11. Pecoul B., Pollastri M., McKerrow J., et al. Ask the Experts. Future Med. Chem. 2012 ; 4: 1383-1389
12. Pecoul B. New Drugs for Neglected Diseases: From Pipeline to Patients. PLoS Med. 2004 ; 1: e6
13. Kotz J. Phenotypic Screening, Take Two. Science Business Exchange. 2012 ; 5: 3
14. Swinney D. C., Anthony J. How Were New Medicines Discovered?. Nat. Rev. Drug Discov. 2011 ; 10: 507-519
15. Chatelain E., Ioset J. R. Drug Discovery and Development for Neglected Diseases: The DNDi Model. Drug Des. Devel. Ther. 2011 ; 5: 175-181
16. Paveley R. A., Bickle Q. D. Automated Imaging and Other Developments in Whole-Organism Anthelmintic Screening. Parasite Immunol. 2013 ; 35: 302-313
17. Paveley R. A., Mansour N. R., Hallyburton I., et al. Whole Organism High-Content Screening by Label-free, Image-Based Bayesian Classification for Parasitic Diseases. PLoS Negl. Trop. Dis. 2012 ; 6: e1762
18. Marcellino C., Gut J., Lim K. C., et al. WormAssay: A Novel Computer Application for Whole-Plate Motion-Based Screening of Macroscopic Parasites. PLoS Negl. Trop. Dis. 2012 ; 6: e1494
19. Jones A. J., Avery V. M. Whole-Organism High-Throughput Screening against. Trypanosoma brucei brucei. Expert Opin. Drug Discov. 2013 ; 8: 495-507
20. Sykes M. L., Avery V. M. Approaches to Protozoan Drug Discovery: Phenotypic Screening. J. Med. Chem. 2013 ;:
21. Andriani G., Chessler A. D., Courtemanche G., et al. Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening. PLoS Negl. Trop. Dis. 2011 ; 5: e1298
22. Engel J. C., Ang K. K., Chen S., et al. Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease. Antimicrob. Agents Chemother. 2010 ; 54: 3326-3334
23. De Rycker M., Hallyburton I., Thomas J., et al. Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay. Antimicrob. Agents Chemother. 2013 ; 57: 2913-2922
24. Siqueira-Neto J. L., Moon S., Jang J., et al. An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages. PLoS Negl. Trop. Dis. 2012 ; 6: e1671
25. Don R., Ioset J. R. Screening Strategies to Identify New Chemical Diversity for Drug Development to Treat Kinetoplastid Infections. Parasitology. 2013 ;:
26. Balasegaram M., Ritmeijer K., Lima M. A., et al. Liposomal Amphotericin B as a Treatment for Human Leishmaniasis. Expert Opin. Emerg. Drugs. 2012 ; 17: 493-510
27. Chu B. K., Hooper P. J., Bradley M. H., et al. The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). PLoS Negl. Trop. Dis. 2010 ; 4: e708
28. Coffeng L. E., Stolk W. A., Zoure H. G., et al. African Programme for Onchocerciasis Control 1995-2015: Model-Estimated Health Impact and Cost. PLoS Negl. Trop. Dis. 2013 ; 7: e2032
29. Bockarie M. J., Deb R. M. Elimination of Lymphatic Filariasis: Do We Have the Drugs to Complete the Job?. Curr. Opin. Infect. Dis. 2010 ; 23: 617-620
30. Mackenzie C. D., Homeida M. M., Hopkins A. D., et al. Elimination of Onchocerciasis from Africa: Possible?. Trends Parasitol. 2012 ; 28: 16-22
31. Townson S., Ramirez B., Fakorede F., et al. Challenges in Drug Discovery for Novel Antifilarials. Expert Opin. Drug Discov. 2007 ; 2: S63 - S73
32. Nwaka S., Besson D., Ramirez B., et al. Integrated Dataset of Screening Hits against Multiple Neglected Disease Pathogens. PLoS Negl. Trop. Dis. 2011 ; 5: e1412
33. Taylor M. J., Hoerauf A., Townson S., et al. Anti-Wolbachia Drug Discovery and Development: Safe Macrofilaricides for Onchocerciasis and Lymphatic Filariasis. Parasitol. 2013 ;:
34. Taylor M. J., Bandi C., Hoerauf A. Wolbachia Bacterial Endosymbionts of Filarial Nematodes. Adv. Parasitol. 2005 ; 60: 245-284
35. Taylor M. J., Hoerauf A., Bockarie M. Lymphatic Filariasis and Onchocerciasis. Lancet. 2010 ; 376: 1175-1185
36. Anti-Wolbachia Consortium. www.a-wol.com.
37. Johnston K. L., Wu B., Guimaraes A., et al. Lipoprotein Biosynthesis as a Target for Anti-Wolbachia Treatment of Filarial Nematodes. Parasit. Vectors. 2010 ; 3: 99
38. AstraZeneca. Lab Talk: First Open Access High Throughput Screening Project for WIPO. 2013. www.labtalk.astrazeneca.com/collaboration/first-open- access-high-throughput-screening-project-for-wipo/.
39. Townson S., Tagboto S., McGarry H. F., et al. Onchocerca Parasites and Wolbachia Endosymbionts: Evaluation of a Spectrum of Antibiotic Types for Activity against Onchocerca gutturosa In Vitro. Filaria J. 2006 ; 5: 4
40. Hoerauf A., Nissen-Pahle K., Schmetz C., et al. Tetracycline Therapy Targets Intracellular Bacteria in the Filarial Nematode Litomosoides sigmodontis and Results in Filarial Infertility. J. Clin. Invest. 1999 ; 103: 11-18
41. Ash L. R., Riley J. M. Development of Subperiodic Brugia malayi in the Jird, Meriones unguiculatus, with Notes on Infections in Other Rodents. J. Parasitol. 1970 ; 56: 969-973
42. Holman A. G., Davis P. J., Foster J. M., et al. Computational Prediction of Essential Genes in an Unculturable Endosymbiotic Bacterium, Wolbachia of Brugia malayi. BMC Microbiol. 2009 ; 9: e243
43. Lentz C. S., Halls V., Hannam J. S., et al. A Selective Inhibitor of Heme Biosynthesis in Endosymbiotic Bacteria Elicits Antifilarial Activity In Vitro. Chem. Biol. 2013 ; 20: 177-187
44. Wu B., Novelli J., Foster J., et al. The Heme Biosynthetic Pathway of the Obligate Wolbachia Endosymbiont of Brugia malayi as a Potential Anti-filarial Drug Target. PLoS Negl. Trop. Dis. 2009 ; 3: e475
45. Wu B., Novelli J., Jiang D., et al. Interdomain Lateral Gene Transfer of an Essential Ferrochelatase Gene in Human Parasitic Nematodes. Proc. Natl. Acad. Sci. U. S. A. 2013 ; 110: 7748-7753
46. Raverdy S., Foster J. M., Roopenian E., et al. The Wolbachia Endosymbiont of Brugia malayi Has an Active Pyruvate Phosphate Dikinase. Mol. Biochem. Parasitol. 2008 ; 160: 163-166